Probiotic strains guide Ireland showing Lactobacillus and Bifidobacterium families explaine

Probiotic Strains Explained: The Complete Guide for Ireland

Probiotic Strains Explained: The Complete Guide for Ireland

Most probiotic confusion comes from one missing detail: the strain. Two products can list the same species, show the same CFU count, and still behave differently in research because the strain is not identical.

This Ireland-first reference guide explains what a probiotic strain is, how to read labels, the main probiotic families, and examples of strains that are frequently discussed in published research. It also covers how probiotic supplements are regulated in Ireland under Food Safety Authority of Ireland (FSAI) guidance.

Key takeaway: CFU alone is not a shortcut to “best”. Strain identity, dose, storage, and study context matter.


Quick answers

  • What is a probiotic? Live microorganisms that, when administered in adequate amounts, confer a health benefit on the host (the widely used consensus definition). Source: Hill et al., 2014. https://pubmed.ncbi.nlm.nih.gov/24912386/
  • What is a strain? A specific genetic variant within a species (example: Lactobacillus rhamnosus GG).
  • Why strain matters: Research findings are usually tied to a named strain or defined formulation, not to a whole genus or species.
  • How to choose in Ireland: Look for strain names/codes, clear CFU at end-of-shelf-life (if stated), sensible storage instructions, and a reputable manufacturer. Check FSAI supplement guidance: https://www.fsai.ie/business-advice/food-supplements

1) What is a probiotic strain?

Probiotics are described using a basic taxonomy structure:

  • Genus (for example, Lactobacillus)
  • Species (for example, rhamnosus)
  • Strain (for example, GG)

So Lactobacillus rhamnosus GG is more specific than “Lactobacillus” or even “L. rhamnosus”. Most published studies do not test “probiotics” as a single category. They test specific strains or defined multi-strain formulations.

For the consensus definition and scope of probiotics, see Hill et al., 2014: https://pubmed.ncbi.nlm.nih.gov/24912386/


2) Major probiotic families you will see on labels

Lactobacillus (and reclassified lactobacilli)

Many products list lactobacilli (sometimes under newer genus names after taxonomic updates). Common label examples include:

  • L. rhamnosus
  • L. plantarum
  • L. acidophilus
  • L. casei

In published research across different settings, one of the most widely discussed strains is Lactobacillus rhamnosus GG (LGG). A review overviewing LGG research history and applications is available in open access via PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC4006995/

Bifidobacterium

Bifidobacteria are common in many probiotic formulas and are frequently discussed in microbiome research. Common label examples include:

  • B. longum
  • B. infantis
  • B. breve
  • B. bifidum

For background on bifidobacteria in the gut microbiome, see O’Callaghan and van Sinderen: https://pubmed.ncbi.nlm.nih.gov/23518086/


3) Most studied probiotic strains (examples) and what that means

This table is not a “best probiotic” list. It is a reference map showing how research is usually anchored to a specific strain or defined formulation.

Strain / formulation Studied for Key research link
Bifidobacterium infantis 35624 IBS symptom outcomes in a placebo-controlled trial context Whorwell PJ et al. (2006): https://pubmed.ncbi.nlm.nih.gov/16863564/
Probiotics (as a group, multiple strains across trials) IBS global symptoms (meta-analysis synthesis; results vary by strain, dose, and duration) Ford AC et al. (2018): https://pubmed.ncbi.nlm.nih.gov/29704268/
IBS probiotics evidence (multi-trial synthesis) IBS outcomes across many RCTs with heterogeneity and moderators (duration, type) Three-level meta-analysis overview (open access): https://pmc.ncbi.nlm.nih.gov/articles/PMC10651259/

If you want an Ireland-first IBS overview, the HSE IBS pages are the correct public-health starting point. HSE IBS overview: https://www2.hse.ie/conditions/irritable-bowel-syndrome/ and treatment context: https://www2.hse.ie/conditions/irritable-bowel-syndrome/treatment/


4) Multi-strain probiotics and why “formulation” matters

Some products use multiple strains in one formula. In research and regulation, what matters is whether the formulation is clearly defined and repeatable.

In IBS and broader gut-health discussions, one recurring point is that outcomes can differ when:

  • Strains are changed
  • Doses are changed
  • Manufacturing process or quality controls differ
  • Storage and viability differ

For an open-access discussion of probiotic formulation identity and manufacturing differences, see De Simone (Frontiers in Medicine, 2021): https://pmc.ncbi.nlm.nih.gov/articles/PMC7882405/


5) How to read probiotic labels in Ireland

CFU count

  • CFU means colony-forming units. It is a count, not a guarantee of outcome.
  • Check whether the label states CFU at manufacture or at end of shelf life. If it is not stated, treat the number as incomplete information.

Strain codes and transparency

  • Prefer labels that list full names like Genus species strain.
  • “Lactobacillus acidophilus” without a strain is less research-specific than “L. acidophilus LA-14” (example format).

Storage conditions

  • Some probiotics are shelf-stable, others require cold storage.
  • Follow label storage instructions. Viability can be affected by heat and humidity.

Capsule vs sachet

  • Format changes practical use (travel, mixing, timing) and sometimes storage needs.
  • Format does not automatically mean “stronger” or “better”. Strain identity and dose still matter.

6) Are probiotics regulated in Ireland?

In Ireland, probiotic products sold as supplements are treated as food supplements. That means labelling and marketing claims must follow applicable food supplement and claims rules.

FSAI guidance (starting point): https://www.fsai.ie/business-advice/food-supplements

If you are comparing products, avoid anything making disease-treatment claims. That is a fast way to filter out low-quality marketing.


7) How to choose a probiotic in Ireland

Use this checklist:

  • Strains listed clearly (genus, species, strain)
  • CFU stated clearly, ideally with end-of-shelf-life clarity
  • Storage instructions make sense and match the format
  • Ingredients are transparent (no vague proprietary blends hiding strain identity)
  • Brand is reputable and consistent in labelling

If you want an Ireland-wide foundational guide, see:

Where CDS22 fits (neutral reference): If you are comparing high-strength multi-strain options, you can review the CDS22 range and format options here: CDS22-formula Probiotic collection. Compare by strain transparency, CFU disclosure, format, and suitability for your own situation.


Frequently Asked Questions

What probiotic strains are best studied?

Research is strain- and condition-specific. Many IBS discussions reference specific strains (for example B. infantis 35624) and also broader meta-analyses pooling many different strains and trial designs. See Whorwell (2006): https://pubmed.ncbi.nlm.nih.gov/16863564/ and Ford (2018): https://pubmed.ncbi.nlm.nih.gov/29704268/

What is the difference between Lactobacillus and Bifidobacterium?

They are different genera. Both appear in many probiotic products, and both include many species and strains. Effects discussed in studies depend on the exact strain or formulation used. For bifidobacteria background: https://pubmed.ncbi.nlm.nih.gov/23518086/

Are probiotics regulated in Ireland?

Probiotic supplements are treated as food supplements in Ireland. FSAI provides business and consumer guidance as a starting point: https://www.fsai.ie/business-advice/food-supplements

Do probiotics survive stomach acid?

Survival depends on the strain, dose, formulation, and delivery technology (for example capsule design). Label instructions and the manufacturer’s strain transparency are your practical starting points.


Sources

  1. Hill C et al. (2014) ISAPP consensus statement on probiotics definition and scope: https://pubmed.ncbi.nlm.nih.gov/24912386/
  2. O’Callaghan A, van Sinderen D. Bifidobacteria and the gut (review): https://pubmed.ncbi.nlm.nih.gov/23518086/
  3. Whorwell PJ et al. (2006) B. infantis 35624 trial in IBS: https://pubmed.ncbi.nlm.nih.gov/16863564/
  4. Ford AC et al. (2018) Systematic review and meta-analysis of probiotics in IBS: https://pubmed.ncbi.nlm.nih.gov/29704268/
  5. IBS probiotics synthesis (open access): https://pmc.ncbi.nlm.nih.gov/articles/PMC10651259/
  6. De Simone (Frontiers in Medicine, 2021) on formulation/manufacturing identity (open access): https://pmc.ncbi.nlm.nih.gov/articles/PMC7882405/
  7. FSAI Food Supplements guidance: https://www.fsai.ie/business-advice/food-supplements
  8. HSE IBS overview: https://www2.hse.ie/conditions/irritable-bowel-syndrome/
  9. HSE IBS treatment context: https://www2.hse.ie/conditions/irritable-bowel-syndrome/treatment/